|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.48 USD | -0.19% |
|
-2.57% | -28.06% |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.19% | -2.57% | -2.23% | -4.10% | -28.06% | +11.48% | +41.87% | +44.70% | +150.64% | 1.09B | |
| +0.24% | -2.34% | +3.57% | +21.13% | +2.63% | +43.12% | +140.99% | +398.09% | +1,409.47% | 980B | |
| +0.45% | -2.64% | -2.09% | -2.54% | +10.87% | +51.63% | +38.53% | +40.23% | +97.01% | 550B | |
| +4.64% | +2.06% | +4.84% | +10.35% | -1.02% | +23.07% | +64.58% | +97.17% | +274.48% | 382B | |
| -0.48% | -3.09% | -3.21% | +6.28% | -2.56% | +23.33% | +16.78% | -8.41% | +30.00% | 316B | |
| +0.30% | +0.27% | -4.92% | -3.71% | -4.05% | +26.99% | +14.07% | +58.47% | +240.42% | 272B | |
| +0.95% | -1.05% | -0.42% | +2.45% | +8.54% | +25.12% | +32.09% | +38.66% | +54.80% | 268B | |
| +0.87% | +2.82% | +1.64% | +24.84% | -9.68% | -34.82% | -45.90% | +14.46% | +68.97% | 199B | |
| +1.41% | -2.41% | +0.98% | -2.04% | +4.68% | +25.76% | +49.19% | +42.81% | +128.70% | 182B | |
| +0.29% | -0.48% | -7.93% | -9.93% | +0.79% | +16.49% | +58.37% | +84.50% | +50.04% | 154B | |
| -0.58% | -2.98% | -2.61% | -5.77% | +1.30% | +4.97% | -34.87% | -36.32% | -26.82% | 144B | |
| +2.65% | +2.53% | +6.30% | +2.36% | +1.88% | +4.13% | +32.66% | +144.55% | +441.98% | 115B | |
| +0.36% | -3.81% | -9.01% | -5.09% | +0.30% | +15.30% | -17.15% | -17.96% | -25.18% | 110B | |
| -2.55% | -4.43% | -6.10% | -6.04% | -12.73% | -13.10% | -26.05% | -17.71% | +1.43% | 102B | |
| -0.27% | -2.20% | -0.10% | -1.24% | +4.85% | +36.35% | +40.77% | +9.72% | +7.81% | 101B | |
| -0.37% | +1.27% | -7.02% | -5.35% | -8.75% | +0.16% | +76.41% | +72.13% | +524.23% | 77.05B | |
| +0.83% | -2.22% | -2.62% | -10.79% | +2.90% | +16.13% | +8.41% | +32.60% | +12.76% | 48.34B | |
| +3.04% | -0.14% | -5.89% | -12.19% | -18.72% | -6.45% | +4.35% | -30.34% | +232.97% | 47.32B | |
| -0.83% | +3.14% | -2.75% | -2.64% | +1.19% | +42.75% | -25.84% | -27.00% | -59.22% | 42.64B | |
| -0.48% | -0.75% | -3.26% | -9.03% | -11.26% | -13.39% | +2.34% | - | - | 39.01B | |
| Average | +0.56% | -1.90% | -2.14% | -0.65% | -2.85% | +14.95% | +23.58% | +49.49% | +190.24% | 206.5B | |
| Weighted average by Cap. | +0.77% | -3.15% | -0.35% | +5.84% | +1.30% | +26.20% | +51.91% | +124.58% | +432.19% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
